Results 201 to 210 of about 83,645 (265)

Development and characterization of high-efficiency cell-adapted live attenuated vaccine candidate against African swine fever. [PDF]

Emerg Microbes Infect
Kim MH, Subasinghe A, Kim Y, Kwon HI, Cho Y, Chathuranga K, Cha JW, Moon JY, Hong JH, Kim J, Lee SC, Dodantenna N, Gamage N, Chathuranga WAG, Kim Y, Yoon IJ, Lee JY, Mo IP, Jheong W, Yoo SS, Lee JS.   +20 more
europepmc   +1 more source

IgE‐Binding Bacterial Components Not Yet Documented in the Allergen Databases and Their Allergenic Mechanisms: An EAACI Position Paper

Allergy, EarlyView.
ABSTRACT Among bacteria that are associated with the development and/or exacerbation of allergic/atopic diseases, several have been described to produce IgE‐binding components. However, only one bacterial protein, Bac s 1, is currently listed in the official database of the World Health Organization/International Union of Immunological Societies (WHO ...
Uta Jappe, Marua Abu Risha, Ioana Agache, Claus Bachert, Barbara Bröker, Riccardo Castagnoli, Gabriele Gadermaier, Richard E. Goodman, Amir Guemari, Christiane Hilger, Alain Jacquet, Sabine Kespohl, Ludger Klimek, Annette Kuehn, Jonas Lidholm, Vera Mahler, Markus Ollert, Thomas A. Platts‐Mills, Monika Raulf, Peter Schmid‐Grendelmeier, Frieder Schmiedeke, Marianne van Hage, Joana Vitte, Josefina Zakzuk, Anna Pomés   +24 more
wiley   +1 more source

A safer cell-based yellow fever live attenuated vaccine protects mice against YFV infection. [PDF]

iScience
Guo W, Jiang T, Rao J, Zhang Z, Zhang X, Su J, Yin C, Lu M, Hu X, Shan C.   +9 more
europepmc   +1 more source

Safety and Immunogenicity of the Live Attenuated Vaccine QazCOVID-Live Against Coronavirus Infection COVID-19: Pre-Clinical Study Results. [PDF]

Vaccines (Basel)
Kutumbetov L, Myrzakhmetova B, Tussipova A, Zhapparova G, Tlenchiyeva T, Bissenbayeva K, Zhapar K, Zhugunissov K, Nurabayev S, Kerimbayev A.   +9 more
europepmc   +1 more source

A live attenuated vaccine to prevent severe neonatal Escherichia coli K1 infections. [PDF]

Nat Commun
Sereme Y, Schrimp C, Faury H, Agapoff M, Lefebvre-Wloszczowski E, Chang Marchand Y, Ageron-Ardila E, Panafieu E, Blec F, Coureuil M, Frapy E, Tsatsaris V, Bonacorsi S, Skurnik D.   +13 more
europepmc   +1 more source

Development of a live attenuated vaccine candidate for equid alphaherpesvirus 1 control: a step towards efficient protection. [PDF]

Front Immunol
Hu Y, Wu G, Jia Q, Zhang B, Sun W, Sa R, Zhang S, Cai W, Jarhen, Ran D, Liu J.   +10 more
europepmc   +1 more source

Mucosal bivalent live attenuated vaccine protects against human metapneumovirus and respiratory syncytial virus in mice. [PDF]

NPJ Vaccines
Ogonczyk-Makowska D, Brun P, Vacher C, Chupin C, Droillard C, Carbonneau J, Laurent E, Dulière V, Traversier A, Terrier O, Julien T, Galloux M, Paul S, Eléouët JF, Fouret J, Hamelin ME, Pizzorno A, Boivin G, Rosa-Calatrava M, Dubois J.   +19 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Influenza Vaccination with a Live Attenuated Vaccine

AJN, American Journal of Nursing, 2009
Influenza is a highly contagious, acute respiratory illness with a long history of outbreaks dating back several centuries. Although immunization is an effective means of protection against influenza, vaccination rates have been suboptimal, especially among certain high-risk groups, including children and health care personnel.
Michele, Michael, Elizabeth, Helm, Brigit, Van Graafeiland, Frank, Malinoski, Jay, Bauman   +4 more
openaire   +2 more sources

LIVE ATTENUATED VARICELLA VACCINE

Annual Review of Microbiology, 1996
Varicella-zoster virus (VZV) is a ubiquitous human pathogen that causes varicella, commonly called chicken pox; establishes latency; and reactivates as herpes zoster, referred to as shingles. A live attenuated varicella vaccine, derived from the Oka strain of VZV has clinical efficacy for the prevention of varicella.
A M, Arvin, A A, Gershon
openaire   +2 more sources